Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
West · Arizona
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Tucson (550,000 residents, 1,060,000 metro). University of Arizona Health Sciences anchors academic care; AHCCCS generally covers T2D GLP-1s with prior auth.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Tucson →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Tucson →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Tucson →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Tucson →
Tucson is a west-region city with a population of 550,000 (1,060,000 in the broader metropolitan area). Arizona expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include Banner Health, Mayo Clinic Arizona.
Arizona's Medicaid program is AHCCCS (Arizona Health Care Cost Containment System). Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.